COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,612 Articles (22,913 medRxiv, 8,699 bioRxiv)

Most recent first Previous |  Page 2431: Articles 24301-24310  | Next

Respiratory viral infections by Non-influenza viruses are associated with more adverse clinical outcome in patients with underlying liver disease: a single centre laboratory based study.
Gupta, E., Padhi, A., Agarwal, K., Ramachandran, K., Aggarwal, R., Pasupuleti, S. S. R., Bhattacharyya, D., Maiwall, R., Sarin, S. K.
10.1101/2020.08.01.20166330 — Posted: 2020-08-04
Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification.
Garneret, P., Coz, E., Martin, E., Manuguerra, J.-C., Brient-Litzler, E., Enouf, V., Gonzalez Obando, D. F., Olivo-Marin, J.-C., Monti, F., Van der Werf, S., Vanhomwegen, J., Tabeling, P. J.
10.1101/2020.08.01.20166538 — Posted: 2020-08-04 Discussion: Offsite
On the temporal spreading of the SARS-CoV-2
Bertacchini, F., Bilotta, E., Pantano, P. S.
10.1101/2020.08.01.20166447 — Posted: 2020-08-04
Sensitivity of nasopharyngeal, oropharyngeal and nasal washes specimens for SARS-CoV-2 detection in the setting of sampling device shortage
Calame, A., Mazza, L., Renzoni, A., Kaiser, L., Schibler, M.
10.1101/2020.08.01.20166397 — Posted: 2020-08-04
Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreak
Endo, A., Centre for the Mathematical Modelling of Infectious Diseases (CMMID) COVID-19 Working Group, , Leclerc, Q. J., Knight, G. M., Medley, G. F., Atkins, K. E., Funk, S., Kucharski, A. J.
10.1101/2020.08.01.20166595 — Posted: 2020-08-04 Discussion: Onsite | Offsite
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
Plebani, M., Padoan, A., Sciacovelli, L., Bonfante, F., Pagliari, M., Bozzato, D., Cosma, C., Bortolami, A., Negrini, D., Zuin, S.
10.1101/2020.08.01.20166546 — Posted: 2020-08-04
The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China
Zhang, J., Litvinova, M., Liang, Y., Zheng, W., Shi, H., Vespignani, A., Viboud, C., Ajelli, M., Yu, H.
10.1101/2020.08.03.20167056 — Posted: 2020-08-04
Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using the VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan
Nagura-Ikeda, M., Imai, K., Kubota, K., Noguchi, S., Kitagawa, Y., Matsuoka, M., Tabata, S., Miyoshi, K., Ito, T., Tamura, K., Maeda, T.
10.1101/2020.08.02.20166256 — Posted: 2020-08-04
Retrospective SARS-CoV-2 Real-Time PCR Testing of Stored Bronchoalveolar Lavage Samples from February 2020
Challener, D. W., Shah, A., Binnicker, M., Badley, A., O'Horo, J.
10.1101/2020.08.03.20167320 — Posted: 2020-08-04
Outcome of COVID-19 with co-existing surgical emergencies in children: our initial experiences and recommendations
Hasan, M. S., Ali, M. A., Huq, U.
10.1101/2020.08.01.20166371 — Posted: 2020-08-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).